Date: 2025-10-08Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision (EU) 2025/1647 of the European Parliament of 7 May 2025 on discharge in respect of the implementation of the budget of the European Medicines Agency for the financial year 2023
**Executive Summary**
Decision (EU) 2025/1647 of the European Parliament, dated May 7, 2025, grants discharge to the Executive Director of the European Medicines Agency (EMA) regarding the implementation of the Agency's budget for the financial year 2023. The decision includes observations detailed in a separate resolution, and instructs the President to forward this decision and the resolution to relevant parties for publication. The document was officially published on October 8, 2025.
**Key Points / Main Content**
* **Decision:**
* The European Parliament grants discharge to the Executive Director of the EMA in respect of the implementation of the Agency's budget for the financial year 2023.
* Observations regarding the discharge are outlined in a separate resolution.
* **Instructions:**
* The President of the European Parliament is instructed to forward the decision and the associated resolution to the following entities:
* The Executive Director of the EMA
* The Council
* The Commission
* The Court of Auditors
* The President is also instructed to arrange for the publication of the decision and resolution in the Official Journal of the European Union (L series).
**Impact Analysis**
**European Medicines Agency (EMA) Executive Director**
* **Impact**
* Granted discharge for the implementation of the Agency’s budget for the 2023 financial year.
* Subject to the observations outlined in the resolution attached to the decision.
* **Action Required**
* Review and address observations made in the resolution.
**Council, Commission, and Court of Auditors**
* **Impact**
* Informed of the Parliament's decision and the related observations.
* **Action Required**
* Review the decision and resolution upon receipt.
**President of the European Parliament**
* **Impact**
* Responsible for the formal communication and publication of the decision.
* **Action Required**
* Forward the decision and resolution to the specified entities.
* Arrange for publication in the Official Journal of the European Union (L series).
Key Entities Referenced
European Medicines Agency: Central focus of the decision, concerning the discharge of its budget implementation.
European Parliament: The decision originates from the European Parliament.
Regulation (EU, Euratom) 2018/1046: Regulation on the financial rules applicable to the general budget of the Union.
Court of Auditors: Provides the annual report on EU agencies and statement of assurance on the reliability of accounts and underlying transactions.
Council: Issues recommendations on discharge to be given to the Agency.
Official Journal EN
of the European Union L series
2025/1647 8.10.2025
DECISION(EU) 2025/1647 OF THE EUROPEAN PARLIAMENT
of 7 May 2025
on discharge in respect of the implementation of the budget of the European Medicines Agency for
the financial year 2023
THE EUROPEAN PARLIAMENT,
— having regard to the final annual accounts of the European Medicines Agency for the financial year 2023,
— having regard to the Court of Auditors’ annual report on EU agencies for the financial year 2023, together with the
agencies’ replies(1),
— having regard to the statement of assurance(2)as to the reliability of the accounts and the legality and regularity of the
underlying transactions provided by the Court of Auditors for the financial year 2023, pursuant to Article 287 of the
Treaty on the Functioning of the European Union,
— having regard to the Council’s recommendation of 17 February 2025 on discharge to be given to the Agency in
respect of the implementation of the budget for the financial year 2023 (05755/2025 – C10-0024/2025),
— having regard to Article 319 of the Treaty on the Functioning of the European Union,
— having regard to Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July
2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU)
No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU)
No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation
(EU, Euratom) No 966/2012(3), and in particular Article 70 thereof,
— having regard to Regulation (EU, Euratom) 2024/2509 of the European Parliament and of the Council of
23 September 2024 on the financial rules applicable to the general budget of the Union(4), and in particular
Article 70 thereof,
— having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004
laying down Union procedures for the authorisation and supervision of medicinal products for human use and
establishing a European Medicines Agency(5), and in particular Article 68 thereof,
— having regard to Commission Delegated Regulation (EU) 2019/715 of 18 December 2018 on the framework
financial regulation for the bodies set up under the TFEU and Euratom Treaty and referred to in Article 70 of
Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council(6), and in particular
Article 105 thereof,
— having regard to Rule 102 of and Annex V to its Rules of Procedure,
— having regard to the opinions of the Committee on Employment and Social Affairs, the Committee on the
Environment, Climate and Food Safety, the Committee on Transport and Tourism, the Committee on Fisheries, the
Committee on Culture and Education, the Committee on Civil Liberties, Justice and Home Affairs, and the
Committee on Women's Rights and Gender Equality,
— having regard to the report of the Committee on Budgetary Control (A10-0065/2025),
(1) OJ C, C/2024/6332, 24.10.2024, ELI: http://data.europa.eu/eli/C/2024/6332/oj.
(2) OJ C, C/2024/6041, 10.10.2024, ELI: http://data.europa.eu/eli/C/2024/6041/oj.
(3) OJ L 193, 30.7.2018, p. 1, ELI: http://data.europa.eu/eli/reg/2018/1046/oj.
(4) OJ L, 2024/2509, 26.9.2024, ELI: http://data.europa.eu/eli/reg/2024/2509/oj.
(5) OJ L 136, 30.4.2004, p. 1, ELI: http://data.europa.eu/eli/reg/2004/726/oj.
(6) OJ L 122, 10.5.2019, p. 1, ELI: http://data.europa.eu/eli/reg_del/2019/715/oj.
ELI: http://data.europa.eu/eli/dec/2025/1647/oj 1/2EN
OJ L, 8.10.2025
1. Grants the Executive Director of the European Medicines Agency discharge in respect of the implementation of the
Agency’s budget for the financial year 2023;
2. Sets out its observations in the resolution below;
3. Instructs its President to forward this decision, and the resolution forming an integral part of it, to the Executive
Director of the European Medicines Agency, the Council, the Commission and the Court of Auditors, and to arrange
for their publication in the Official Journal of the European Union(L series).
The President The Secretary-General
Roberta METSOLA Alessandro CHIOCCHETTI
2/2 ELI: http://data.europa.eu/eli/dec/2025/1647/oj